MRDeep study: measurable residual disease rates in patients with multiple myeloma who achieved complete response in 2nd or 3rd lines of treatment
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
multiple myeloma,measurable residual disease rates
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要